ASH 2021
1 interview21 min
American Society of Hematology Annual Meeting
Interviews and expert commentary from ASH 2021 — study authors and key opinion leaders discuss the findings and their clinical implications.

Progression to Acute Myeloid Leukemia Explained by Multi Omics Analysis
ATLANTA, USA—A new research method has elucidated cellular processes (involving mutated TP53 oncogene) that can convert a relatively benign myeloproliferative neoplasm into acute myeloid leukemia. Fin
10 October 2022
21 min